Intellectual Property India Publishes Patent Application for 'Pyrimidine Based Modulators And Uses Thereof' Filed by Quanta Therapeutics, Inc.

MUMBAI, India, March 15 -- Intellectual Property India has published a patent application (202417097125 A) filed by Quanta Therapeutics, Inc., San Francisco, on Dec. 9, 2024, for 'pyrimidine based modulators and uses thereof.'

Inventor(s) include Lin, Hong; Luengo, Juan; Johnson, Neil; Hospital, Audrey; and Zeng, Jin.

The application for the patent was published on March 14, under issue no. 11/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are compounds, such as compounds of Formula (I), Formula (I-A), Formula (I-B), or pharmaceutically acceptable salts of any one there, useful for modulating KRAS GD12 and/or other G12 mutants."

The patent application was internationally filed on May 24, 20...